Conference Throws Spotlight on Growing TB Threat
The 38th World Conference on Lung Health started in Cape Town on 9 November, bringing together more than 3,000 scientists in the ongoing battle agains...
News Center
TB Alliance Advances Two Drugs In Clinical Trials On Path To Faster, Better Tuberculosis Treatments
Trailblazing Phase III Trial Seeks to Shorten TB Treatment; Novel Candidate in Phase II Offers Hope for More Effective, Simpler CureNEW YORK & CAPE TOWN, South Africa--The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership a...
Two New TB Drugs May Reduce Treatment Time
The Global Alliance for Tuberculosis Drug Development (TB Alliance) has announced that it has developed two drugs in clinical trials which could reduc...
Global TB Epidemic May Have Peaked: WHO
CAPE TOWN - The global tuberculosis epidemic seems to have peaked for the first time in history, a senior World Health Organisation official said on T...
Trials Underway on Quicker TB Drugs
Clinical trials were being done with two drugs promising to shorten and simplify tuberculosis treatment, the developers said Thursday on the sidelines...
Treatment of TB to be Examined
Tuberculosis could become the world's leading infectious killer of adults if new drug regimens, already in the pipeline, are not fast-tracked into...
Globe plagued by TB germ warfare
We've seen it before with statistics surrounding HIV/Aids. Now the virus's deadly twin, tuberculosis, is taking the HIV/Aids onslaught to frig...
Field trials aim to tackle poverty
Pioneering lab applies medical sense to development projects.Faced with the multitude of problems that result from and contribute to poverty, how can you decide which strategy to use to tackle an issue? One inno...
Long dormant, antibiotic pipeline flowing again with more than 120 compounds in development
After years of concern about the dearth of new bacteria-fighting drugs, researchers are investigating a greater number of novel compounds than ever before.In the war against drug-resistant bacteria, physicians finally might start getting some new weapons.Experts have long complained that the lack of new ...
New Tuberculosis Therapeutics: A Growing Pipeline
Novel chemotherapeutic drugs are needed to improve tuberculosis (TB) control, especially in the developing world. Given the magnitude of the probl...
News Center Search
Press Contact: press@tballiance.org
TB Alliance Publications
Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis
New TB Regimens: What Countries Want
Pathway to Patients
Policy on the Compassionate / Emergency Use of Experimental TB Alliance Drugs
TB In The News
Site by Darby Communications
© 2013 Global Alliance for TB Drug Development